Ticker brief
ARKG ARK GENOMIC REVOLUTION ETF
last close
$47.64
1 day
-4.5%
14 days
+9.6%
mkt cap
·
signals 14d
58
authors 14d
36
crowd 14d
+0.0σ
Options inteloptions-surface reads · latest available day per source
| metric | reading | context |
|---|---|---|
| IV — ATM 30d | 48% mid · 54 pctile own 1y | IV/HV 1.28× (as of 2026-07-31) |
| Skew — 25Δ RR 30d | +0.067 99 pctile own 1y | calls bid vs puts (call skew rich) |
| OI alarm | quiet | last alarm 2026-06-30 (z=2.3) |
Sentiment — last 14 days
daily mean sentiment, 2026-08-15 → 2026-08-28 · now -0.00 (−1 bearish … +1 bullish)
Who spoke36
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @cfromhertz | B | -0.21 | 8 | +0.44 |
| @TedHZhang | B | +0.57 | 5 | +0.41 |
| @ShardiB2 | C | -0.13 | 3 | +0.73 |
| @CryptoHotep | C | -0.18 | 2 | +0.23 |
| @schaeffers | C | +3.18 | 2 | +0.00 |
| @cfaryanoconnell | C | -1.48 | 2 | +0.00 |
| @alphacharts | B | -3.11 | 2 | +0.25 |
| @salmaogs | C | · | 2 | +0.27 |
| @KeithTradeSmith | C | +0.25 | 2 | +0.62 |
| @VolumeLeaders | A | +0.98 | 2 | -0.12 |
| @cantonmeow | B | -2.35 | 2 | +0.62 |
| @Nice_Stock_ | C | -1.23 | 2 | +0.35 |
| @ThePupOfWallSt | C | -0.47 | 1 | +0.50 |
| @orrdavid | A | +0.01 | 1 | +0.35 |
| @ClassicRoy | C | -1.52 | 1 | +0.00 |
| @DDBlakeFischer | A | -0.00 | 1 | +0.40 |
| @ElysiumEffect | C | -0.84 | 1 | +0.60 |
| @Micro2Macr0 | C | +1.82 | 1 | +0.55 |
| @gregrieben | C | -1.04 | 1 | +0.70 |
| @chad_ventures | C | -1.84 | 1 | +0.65 |
| @PatrickWalker56 | C | -0.04 | 1 | +0.45 |
| @AsafNaamani | C | -3.38 | 1 | +0.75 |
| @Markadiusz45 | C | +1.18 | 1 | +0.45 |
| @SRxTrades | C | -1.52 | 1 | +0.85 |
| @enrichtrades | C | -0.62 | 1 | +0.48 |
Recent signals30of 58 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-08-28 | @CryptoHotep | -0.15 | Says the anticipated breakout has not occurred. | — | tweet ↗ |
| 2026-08-28 | @VolumeLeaders | -0.50 | Large trades sit above price while prior ATR-ribbon tests marked local tops. | — | tweet ↗ |
| 2026-08-28 | @KeithTradeSmith | +0.65 | Bullish long-term preventive-diagnostics basket supported by price and market-growth data. | — | tweet ↗ |
| 2026-08-27 | @TedHZhang | +0.40 | Author highlights genomics, crypto and software transitioning into stage-two uptrends. | -4.5% | tweet ↗ |
| 2026-08-26 | @cfromhertz | +0.25 | Points to healthcare broadly and names biotech-focused ETFs as examples. | -3.7% | tweet ↗ |
| 2026-08-25 | @cfromhertz | +0.35 | Market recap reports strength across biotech, uranium, crypto and mining while listing reviewed charts. | -4.8% | tweet ↗ |
| 2026-08-25 | @jrouldz | +0.75 | Discloses a long-term ARKG holding, averaged into during 2024-25, with no plans to sell after a 2x gain. | -4.8% | tweet ↗ |
| 2026-08-25 | @cantonmeow | +0.50 | Declares a chart breakout in ARKG without stating a trade entry. | -4.8% | tweet ↗ |
| 2026-08-25 | @IncomeSharks | +0.65 | Notes ARKG doubled from yearly lows yet remains 128% below the gain required to revisit its ATH. | -4.8% | tweet ↗ |
| 2026-08-25 | @ShardiB2 | +0.75 | Calls ARKG's move a biotech-sector breakout. | -4.8% | tweet ↗ |
| 2026-08-25 | @cfromhertz | +0.55 | Says genomics, biotech and healthcare ETFs are showing leadership despite muted social sentiment. | -4.8% | tweet ↗ |
| 2026-08-25 | @ShardiB2 | +0.65 | Says ARKG is breaking out as well. | -4.8% | tweet ↗ |
| 2026-08-25 | @cfromhertz | +0.15 | Watchlist notes AI strength and plans to monitor biotech and genomics after a rest day. | -4.8% | tweet ↗ |
| 2026-08-24 | @Nice_Stock_ | +0.30 | Lists ARKG's leading portfolio weights and calls its holdings currently popular. | -0.8% | tweet ↗ |
| 2026-08-24 | @Nice_Stock_ | +0.40 | Says ARKG is among Cathie Wood's better-performing ETFs. | -0.8% | tweet ↗ |
| 2026-08-23 | @TedHZhang | +0.45 | Genomics and healthcare are identified as primary investment themes alongside crypto. | -3.7% | tweet ↗ |
| 2026-08-23 | @cantonmeow | +0.75 | ARKG is described as breaking impulsively from four years of accumulation. | -3.7% | tweet ↗ |
| 2026-08-23 | @TLAMB91 | +0.30 | Views ARKF as an interesting catch-up play while noting unwanted holdings exposure. | -3.7% | tweet ↗ |
| 2026-08-23 | @cfromhertz | +0.55 | Discloses 17% YTD portfolio performance and overweight positions in healthcare ETFs. | -3.7% | tweet ↗ |
| 2026-08-21 | @TheETFTracker | +0.65 | Ranks three ARK ETFs by positive 2026 performance. | -3.7% | tweet ↗ |
| 2026-08-21 | @VolumeLeaders | +0.25 | Reports ARKG's largest trade since inception and a top-ranked TEM print. | -3.7% | tweet ↗ |
| 2026-08-21 | @KeithTradeSmith | +0.60 | Frames a positive cancer-vaccine readout as confirmation of a multiyear healthcare bull theme. | -3.7% | tweet ↗ |
| 2026-08-21 | @PolycarpFX | +0.00 | Flags a leading volume print but asks whether ARKG will rise or fall | -3.7% | tweet ↗ |
| 2026-08-21 | @NirAoo7 | +0.50 | Flags a high-volume signal in the genomics ETF with enthusiastic tone | -3.7% | tweet ↗ |
| 2026-08-21 | @MarketMaestro1 | +0.20 | Endorses a chart path shown only by an image arrow. | -3.7% | tweet ↗ |
| 2026-08-21 | @ShardiB2 | +0.80 | Sees ARKG nearing a major breakout from a four-and-a-half-year base and expects biotech strength. | -3.7% | tweet ↗ |
| 2026-08-21 | @cfromhertz | +0.55 | ARKG is described as very strong despite being short-term overbought. | -3.7% | tweet ↗ |
| 2026-08-20 | @MrFib011235813 | +0.75 | Discloses a long-term ARKG purchase based on AI-driven biotech breakthroughs. | +0.0% | tweet ↗ |
| 2026-08-20 | @cevikfinance | -0.25 | Reports ARKG's 12-year return and the gain required to revisit its all-time high. | +0.0% | tweet ↗ |
| 2026-08-20 | @fundmyfund | +0.50 | Says genomics stocks are resuming positive momentum. | +0.0% | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.